Search Results

Identifying a predictive level of serum C-terminal telopeptide associated with a low risk of medication-related osteonecrosis of the jaw secondary to oral surgery: A systematic review and meta-analysis.

• Authors : Ghio, Camille¹ (AUTHOR); Gravier-Dumonceau, Robinson² (AUTHOR); Lafforgue, Pierre¹ (AUTHOR)

Subjects: *Oral surgery; *Osteonecrosis; *Diphosphonates

• Source: PLoS ONE. 5/5/2025, Vol. 20 Issue 5, p1-14. 14p.

Record details

Dental Implant Survival and Risk of Medication-Related Osteonecrosis in the Jaws in Patients Undergoing Antiresorptive Therapy: A Systematic Review.

• Authors : Crupi, Armando¹ (AUTHOR); Lanzetti, Jacopo¹ (AUTHOR); Todaro, Daniela¹ (AUTHOR)

Subjects: *Dental implants; *Oral medication; *Osteonecrosis

• Source: International Journal of Molecular Sciences. Apr2025, Vol. 26 Issue 8, p3618. 15p.

Record details

Multidisciplinary approach for medication-related osteonecrosis of the jaws: a case report and literature review.

• Authors : Annamalai, Senthilkumar¹; Kamalakaran, Arunkumar¹ ; Jayaraman, Balaji¹

• Source: Archives of Craniofacial Surgery. Apr2025, Vol. 26 Issue 2, p70-75. 6p.

Record details

Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease.

• Authors : Liu, Jiao^1,2,3,4 (AUTHOR); Liu, Shaoshan^1,2,3,4 (AUTHOR); Su, Yuxi^1,2,3,4 (AUTHOR)

• Source: Clinical Kidney Journal. Mar2025, Vol. 18 Issue 3, p1-7. 7p.

Record details

Can Knee Arthroscopy Be Considered Entirely Safe for Patients Over 50 Years Old With no Risk of Osteonecrosis? Case Series and Literature Review on Post-Artrhoscopy Osteonecrosis of the Knee (PAONK).

• Authors : Ntagiopoulos P; Hip and Knee Unit, Mediterraneo Hospital, Athens, Greece.; Kalinterakis G

Subjects: Arthroscopy*/Arthroscopy*/Arthroscopy*/adverse effects ; Osteonecrosis*/Osteonecrosis*/Osteonecrosis*/etiology ; Knee Joint*/Knee Joint*/Knee Joint*/surgery

• Source: Orthopaedic surgery [Orthop Surg] 2025 May; Vol. 17 (5), pp. 1378-1388. Date of Electronic Publication: 2025 Mar 17.Publisher: Wiley on behalf of the Chinese Orthopedic Association Country of Publication: Australia NLM ID: 101501666 Publication Model: Print-Electronic

Record details

Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis (BATON)

• Authors : National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

• Source: Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head

Record details

Gut Microbiota-Derived Butyric Acid Alleviates Glucocorticoid-Associated Osteonecrosis of the Femoral Head via Modulating Inflammatory Cytokines in Bone Marrow Mesenchymal Stem Cells.

• Authors : He S; Department of Orthopedics, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.; Department of Orthopedics, Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, Jiangsu, China.

Subjects: Butyric Acid*/Butyric Acid*/Butyric Acid*/metabolism ; Butyric Acid*/Butyric Acid*/Butyric Acid*/therapeutic use ; Butyric Acid*/Butyric Acid*/Butyric Acid*/pharmacology

• Source: Mediators of inflammation [Mediators Inflamm] 2025 Jun 05; Vol. 2025, pp. 8742817. Date of Electronic Publication: 2025 Jun 05 (Print Publication: 2025).Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: eCollection Cited Medium: Internet ISSN: 1466-1861

Record details

Betaine Alleviates Bisphosphonate-Related Osteonecrosis of the Jaw by Rescuing BMSCs Function in an m6A-METTL3-Dependent Manner.

• Authors : Jin Y; Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Beijing Stomatological Hospital, School of Stomatology, Capital Medical University, Beijing 100050, China.; Song J

Subjects: Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/drug effects ; Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/metabolism ; Bisphosphonate-Associated Osteonecrosis of the Jaw*/Bisphosphonate-Associated Osteonecrosis of the Jaw*/Bisphosphonate-Associated Osteonecrosis of the Jaw*/drug therapy

• Source: International journal of molecular sciences [Int J Mol Sci] 2025 May 29; Vol. 26 (11). Date of Electronic Publication: 2025 May 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Analysis of prosthetic risk factors for peri-implant medication-related osteonecrosis of the jaw: an observational study.

• Authors : Kim DY; Department of Oral and Maxillofacial Surgery, School of Dentistry, Dental Research Institute, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.; Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital, Seoul, Republic of Korea.

Subjects: Dental Implants*/Dental Implants*/Dental Implants*/adverse effects ; Bisphosphonate-Associated Osteonecrosis of the Jaw*/Bisphosphonate-Associated Osteonecrosis of the Jaw*/Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects

• Source: Scientific reports [Sci Rep] 2025 May 08; Vol. 15 (1), pp. 16060. Date of Electronic Publication: 2025 May 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Assessment of Er:YAG Laser-Assisted Surgical Treatment in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Clinical Trial

• Source: Assessment of Er:YAG (Yttrium-aluminium-garnet) Laser-Assisted Surgical Treatment in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Clinical Trial

Record details